CClinicalTrials.gg
Status unknownNCT05801016VIRECUpdated Apr 6, 2023

Virtual Reality and Autobiographical Recall in Anorexia Nervosa: a Preliminary Study

An interventional study of Emerging Technologies and Training in Neurosciences in Anorexia Nervosa, sponsored by Istituto Auxologico Italiano. Status unknown at 1 site in Italy. Open to female participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2023-04-06.

Sponsored by Istituto Auxologico Italiano · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified Mar 2023), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 3 years 8 months after the study started (first participant enrolled Jun 2019, registered Mar 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Non-randomized
Ages
18 Years to 40 Years
Sex
Female
01

Study summary

Clinical trial in patients with Anorexia Nervosa using body-swapping technique e Virtual Reality Body Size estimation tasks and Autobiographic Recall on sympton remission (EDI-3; EDE-Q), body satisfaction and perception

02

Conditions studied

  • Anorexia Nervosa
03

In context

Anorexia

411 studies on the registry are indexed under Anorexia; 67 are open to participants now.

This study's planned enrollment of 20 is below the median of 41 across 287 interventional studies indexed under Anorexia.

Browse Anorexia studies →

Lead sponsor

Istituto Auxologico Italiano is the lead sponsor of 196 studies on the registry; 78 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Anorexia Nervosa
  • Body mass index equal or superior to 15 kg/m2
  • Mother tongue Italian
  • Semiresidential rehabilitation program

Exclusion criteria

Exclusion Criteria:

  • Other eating disorders
  • Neurological disorders , clinical history of cerebral damage, presence of psychiatric disorders
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Other
    Anorexia nervosa

    Female anorexia nervosa patients

    Behavioral: Emerging Technologies and Training in Neurosciences

  • Other
    Healthy controls

    Healthy female control participants

    Behavioral: Emerging Technologies and Training in Neurosciences

Interventions

  • BehavioralEmerging Technologies and Training in Neurosciences

    Combination of body-swapping technique, Virtual Reality Body Size estimation tasks and Autobiographic Recall

06

What researchers measure

Primary outcomes

  1. Change in estimation of body weight

    Overestimation of body weight measured through Eating Disorder Inventory (EDI-3)

    Time frame: At baseline and after 12 months

07

Study locations

1 of 1 sites recruiting
  • Istituto Auxologico Italiano
    Milano, 20100, Italy
    • Luca Persani, MD PhD · Contact · luca.persani@unimi.it · 390261911
    • Giuseppe Riva, prof · Contact · giuseppe.riva@unicatt.it · 390261911
    • Nicoletta Polli, MD · Principal investigator
    • Chiara Cacciatore, MD · Sub investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 6, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05801016
Lead sponsor
Istituto Auxologico Italiano
Responsible party
Sponsor
First posted
Apr 6, 2023
Start date
Jun 28, 2019
Primary completion
Mar 8, 2023
Completion
Jan 2024 (estimated)
Last update
Apr 6, 2023

Study contacts

Luca Persani, MD PhD
Contact
luca.persani@unimi.it;
390261911; ext. -2400 or -2738
Nicoletta Polli, MD
Contact
n.polli@auxologico.it
390261911 ext. 2882
Giuseppe Riva, prof
study director · università cattolica Milano

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion